Document Detail

Beneficial effect of sodium sucrose-sulfate on the ocular surface of patients with severe KCS in primary Sjögren's syndrome.
MedLine Citation:
PMID:  1750307     Owner:  NLM     Status:  MEDLINE    
Sucralfate (aluminium sucrose-sulfate), a well known gastric mucosal protectant, has been tested topically on 22 patients (20 females and 2 males) suffering from primary Sjögren's syndrome. Median treatment period was 6 months (range 1-19 months). Statistically significant improvement in the ocular surface condition was found judged from the reduction in Rose-Bengal score (P less than or equal to 0.00005). The beneficial effect appeared within the first 1-4 months of treatment. No adverse side effects were encountered.
J U Prause
Related Documents :
7887537 - Pyloric channel ulcers: management and three-year follow-up.
6108607 - Treatment of duodenal ulcer with ranitidine, a new histamine h2-receptor antagonist.
18976257 - Efficacy of alpha lipoic acid in burning mouth syndrome: a randomized, placebo-treatmen...
2896967 - Recurrence of duodenal ulcer after medical treatment.
21354977 - Double-blind clinical trial of thalamic stimulation in patients with tourette syndrome.
21345817 - Debridement alone without decortication can achieve lung re-expansion in patients with ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Acta ophthalmologica     Volume:  69     ISSN:  0001-639X     ISO Abbreviation:  Acta Ophthalmol (Copenh)     Publication Date:  1991 Aug 
Date Detail:
Created Date:  1992-01-23     Completed Date:  1992-01-23     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0370347     Medline TA:  Acta Ophthalmol (Copenh)     Country:  DENMARK    
Other Details:
Languages:  eng     Pagination:  417-21     Citation Subset:  IM    
Eye Pathology Institute, University of Copenhagen, Denmark.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Topical
Cornea / pathology
Keratoconjunctivitis Sicca / complications,  drug therapy*
Middle Aged
Rose Bengal / diagnostic use
Sjogren's Syndrome / complications,  drug therapy*
Sucralfate / therapeutic use*
Tears / metabolism
Reg. No./Substance:
11121-48-5/Rose Bengal; 54182-58-0/Sucralfate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Morphologic studies of endometrial cancer for biological assessment of nuclear grading
Next Document:  Correlation of conjunctival impression cytology results with lacrimal function and age.